Company Filing History:
2 out of 1,309 
2 out of 111 
Years Active: 2016-2017
Title: The Innovative Contributions of Lars Ekman
Introduction
Lars Ekman is a notable inventor based in La Jolla, California. He has made significant contributions to the field of immunotherapy, particularly in relation to Alzheimer's disease. With a total of 2 patents, his work has the potential to impact the treatment of neurodegenerative diseases.
Latest Patents
Lars Ekman's latest patents include innovative methods for immunotherapy that are tailored to the ApoE genotype of patients. The first patent, titled "Immunotherapy regimes dependent on ApoE status," provides methods for administering immunotherapy based on the genetic profile of the patient. The second patent, "Use of tau to monitor immunotherapy," outlines methods for monitoring the effectiveness of immunotherapy by measuring levels of tau protein in patients.
Career Highlights
Throughout his career, Lars has worked with prominent companies in the pharmaceutical industry, including Wyeth and Janssen Sciences Ireland Uc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of immunotherapy.
Collaborations
Lars has collaborated with esteemed colleagues such as Ronald Black and Ivan Lieberburg. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Lars Ekman's contributions to immunotherapy represent a significant advancement in the treatment of Alzheimer's disease. His innovative patents and collaborations highlight his commitment to improving patient outcomes through targeted therapies.